Back to search
FDAFDA · Food and drugs·Recall number D-0902-2023

Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 15-count cartons, Distributed By: Adusa Distribution, LLC, Salisbury, NC 28147. NDC 72476-847-22

Published July 19, 2023 · Recall initiated: February 9, 2023

Summary

FDA records drug Class II recall D-0902-2023, published July 19, 2023 and initiated February 9, 2023. Recalling firm: L. Perrigo Company; Status: Terminated; Reported quantity: 3,240 cartons; Lot: Lot #: 2JE2185, Exp. date 01/24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if CAREONE ALLERGY RELIEF has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CAREONE ALLERGY RELIEF
Manufacturer
L. Perrigo Company
Distributor
Nationwide within the USA
Lot
Lot #: 2JE2185, Exp. date 01/24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 15-count cartons, Distributed By: Adusa Distribution, LLC, Salisbury, NC 28147. NDC 72476-847-22 recalled?

Yes. FDA published recall D-0902-2023 on July 19, 2023. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CAREONE ALLERGY RELIEF.